4,071 research outputs found

    Age and sex-selective predation moderate the overall impact of predators

    Get PDF
    © 2014 The Authors. Journal of Animal Ecology published by John Wiley & Sons Ltd on behalf of British Ecological Society. Acknowledgements: Thanks to J. Reid, S. Redpath, A. Beckerman and an anonymous reviewer for their helpful comments on a previous version of the manuscript. This work was partly funded by a Natural Environment Research Council studentship NE/J500148/1 to SH and a grant NE/F021402/1 to XL and by Natural Research Limited. Forest Research funded all the fieldwork on goshawks, tawny owls and field voles during 1973–1996. We thank B. Little, P. Hotchin, D. Anderson and all field assistants for their help with data collection and Forest Enterprise, T. Dearnley and N. Geddes for allowing and facilitating work in Kielder Forest. In addition, we are grateful to English Nature and the BTO for kindly issuing licences annually visit goshawk nest sites. Data accessibility: All data associated with the study which have not already been given in the text are available from the Dryad Digital Repository: http://doi.org/10.5061/dryad.h1289 (Hoy et al. 2014).Peer reviewedPublisher PD

    Optical Spectroscopic Survey of High-latitude WISE-selected Sources

    Get PDF
    We report on the results of an optical spectroscopic survey at high Galactic latitude (|b| ≥ 30°) of a sample of WISE-selected targets, grouped by WISE W1 (λ_eff = 3.4 μm) flux, which we use to characterize the sources WISE detected. We observed 762 targets in 10 disjoint fields centered on ultraluminous infrared galaxy candidates using DEIMOS on Keck II. We find 0.30 ± 0.02 galaxies arcmin–2 with a median redshift of z = 0.33 ± 0.01 for the sample with W1 ≥ 120 μJy. The foreground stellar densities in our survey range from 0.23 ± 0.07 arcmin–2 to 1.1 ± 0.1 arcmin–2 for the same sample. We obtained spectra that produced science grade redshifts for ≥90% of our targets for sources with W1 flux ≥120 μJy that also had an i-band flux gsim 18 μJy. We used this for targeting very preliminary data reductions available to the team in 2010 August. Our results therefore present a conservative estimate of what is possible to achieve using WISE's Preliminary Data Release for the study of field galaxies

    Surface Geometry of C60 on Ag(111)

    Get PDF
    The geometry of adsorbed C60 influences its collective properties. We report the first dynamical low-energy electron diffraction study to determine the geometry of a C60 monolayer, Ag(111)-(23×23)30°-C60, and related density functional theory calculations. The stable monolayer has C60 molecules in vacancies that result from the displacement of surface atoms. C60 bonds with hexagons down, with their mirror planes parallel to that of the substrate. The results indicate that vacancy structures are the rule rather than the exception for C60 monolayers on close-packed metal surfaces. © 2009 The American Physical Society

    Characterization of ellipses as uniformly dense sets with respect to a family of convex bodies

    Full text link
    Let K \subset R^N be a convex body containing the origin. A measurable set G \subset R^N with positive Lebesgue measure is said to be uniformly K-dense if, for any fixed r > 0, the measure of G \cap (x + rK) is constant when x varies on the boundary of G (here, x + rK denotes a translation of a dilation of K). We first prove that G must always be strictly convex and at least C1,1-regular; also, if K is centrally symmetric, K must be strictly convex, C1,1-regular and such that K = G - G up to homotheties; this implies in turn that G must be C2,1- regular. Then for N = 2, we prove that G is uniformly K-dense if and only if K and G are homothetic to the same ellipse. This result was already proven by Amar, Berrone and Gianni in [3]. However, our proof removes their regularity assumptions on K and G and, more importantly, it is susceptible to be generalized to higher dimension since, by the use of Minkowski's inequality and an affine inequality, avoids the delicate computations of the higher-order terms in the Taylor expansion near r = 0 for the measure of G\cap(x+rK) (needed in [3])

    A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification

    Get PDF
    Background:Approximately 5%-10% of gastric cancers have a fibroblast growth factor receptor-2 (FGFR2) gene amplification. AZD4547 is a selective FGFR-1, 2, 3 tyrosine kinase inhibitor with potent preclinical activity in FGFR2 amplified gastric adenocarcinoma SNU16 and SGC083 xenograft models. The randomized phase II SHINE study (NCT01457846) investigated whether AZD4547 improves clinical outcome versus paclitaxel as second-line treatment in patients with advanced gastric adenocarcinoma displaying FGFR2 polysomy or gene amplification detected by fluorescence in situ hybridization. Patients and methods:Patients were randomized 3:2 (FGFR2 gene amplification) or 1:1 (FGFR2 polysomy) to AZD4547 or paclitaxel. Patients received AZD4547 80 mg twice daily, orally, on a 2 weeks on/1 week off schedule of a 21-day cycle or intravenous paclitaxel 80 mg/m2 administered weekly on days 1, 8, and 15 of a 28-day cycle. The primary end point was progression-free survival (PFS). Safety outcomes were assessed and an exploratory biomarker analysis was undertaken. Results:Of 71 patients randomized (AZD4547 n = 41, paclitaxel n = 30), 67 received study treatment (AZD4547 n = 40, paclitaxel n = 27). Among all randomized patients, median PFS was 1.8 months with AZD4547 and 3.5 months with paclitaxel (one-sided P = 0.9581); median follow-up duration for PFS was 1.77 and 2.12 months, respectively. The incidence of adverse events was similar in both treatment arms. Exploratory biomarker analyses revealed marked intratumor heterogeneity of FGFR2 amplification and poor concordance between amplification/polysomy and FGFR2 mRNA expression. Conclusions:AZD4547 did not significantly improve PFS versus paclitaxel in gastric cancer FGFR2 amplification/polysomy patients. Considerable intratumor heterogeneity for FGFR2 gene amplification and poor concordance between FGFR2 amplification/polysomy and FGFR2 expression indicates the need for alternative predictive biomarker testing. AZD4547 was generally well tolerated
    corecore